Muzinich & Co., Inc. Bausch Health Companies Inc. Call Options Transaction History

Muzinich & Co., Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1 Million - $1.2 Million	-40,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $1.1 Million - $1.31 Million	40,000 New	40,000 $1.17 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $1.6 Million - $2.58 Million	-75,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $1.12 Million - $1.51 Million	75,000 New	75,000 $1.14 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Muzinich & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Muzinich & Co., Inc. with notifications on news.